RESEARCH PAPER
Characterization of acute adverse-effect profi le of carbamazepine and valproate in the grip-strength test in mice
 
More details
Hide details
1
Department of Pathophysiology, Medical University, Lublin, Poland; Department of Physiopathology, Institute of Agricultural Medicine, Lublin, Poland
2
Department of Pathophysiology, Medical University, Lublin, Poland
3
Department of Physiopathology, Institute of Agricultural Medicine, Lublin, Poland
CORRESPONDING AUTHOR
Jarogniew J. Łuszczki   

Department of Pathophysiology, Medical University, Jaczewskiego 8, 20-090 Lublin, Poland
 
J Pre Clin Clin Res. 2008;2(1):46–48
KEYWORDS
ABSTRACT
The aim of this study was to assess the acute adverse (neurotoxic) effects of two conventional antiepileptic drugs (carbamazepine and valproate) in the grip-strength test by measuring skeletal muscular strength in mice. Linear regression analysis of dose-response relationship for drug doses and their corresponding skeletal muscular strength allowed the determination of the doses of carbamazepine and valproate that reduced the grip-strength in mice by 50%, as compared to control mice. The experimentally-derived strength reducing dose by 50% for carbamazepine was 80.8 mg/kg, and that for valproate – 501.2 mg/kg. Based on this preclinical study, one can conclude that carbamazepine and valproate reduced in a dose-dependent manner skeletal muscular strength in mice. The grip-strength test can be applied as a paradigm for the evaluation of acute adverse-effect (neurotoxic) profile of drugs with respect to their influence on muscular strength in experimental mice.
 
REFERENCES (8)
1.
Brodie MJ, Schachter SC: Fast Facts. Epilepsy (2nd ed.), Health Press: Oxford 2001.
 
2.
Perucca E: Pharmacological principles as a basis for polytherapy. Acta Neurol Scand Suppl 1995, 162, 31-34.
 
3.
Loscher W, Nolting B: The role of technical, biological and pharmacological factors in the laboratory evaluation of anticonvulsant drugs. IV. Protective indices. Epilepsy Res 1991, 9, 1-10.
 
4.
Motulsky HJ, Christopoulos A: Fitting models to biological data using linear and nonlinear regression. A practical guide to curve fi tting. GraphPad Software Inc, San Diego CA, 2003.
 
5.
Łuszczki JJ, Andres MM, Czuczwar P, Cioczek-Czuczwar A, Wojcik- Cwikła J, Ratnaraj N, Patsalos PN, Czuczwar SJ: Levetiracetam selectively potentiates the acute neurotoxic eff ects of topiramate and carbamazepine in the rotarod test in mice. Eur Neuropsychopharmacol 2005, 15, 609-616.
 
6.
Łuszczki JJ, Czuczwar M, Kis J, Krysa J, Pasztelan I, Świader M, Czuczwar SJ: Interactions of lamotrigine with topiramate and fi rstgeneration antiepileptic drugs in the maximal electroshock test in mice: an isobolographic analysis. Epilepsia 2003, 44, 1003-1013.
 
7.
Łuszczki JJ, Czuczwar SJ: Isobolographic characterization of interactions between vigabatrin and tiagabine in two experimental models of epilepsy. Prog Neuropsychopharmacol Biol Psychiatry 2007, 31, 529-538.
 
8.
Litchfi eld JT, Wilcoxon F: A simplifi ed method of evaluating dose-eff ect experiments. J Pharmacol Exp Ther 1949, 96, 99-113.
 
eISSN:1898-7516
ISSN:1898-2395